Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets

Glaucoma is the second leading cause of blindness worldwide, affecting ~80 million people by 2020 (1, 2). The condition is characterized by a progressive loss of retinal ganglion cells (RGCs) and their axons accompanied by visual field loss. The underlying pathophysiology of glaucoma remains elusive...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: García-Bermúdez, Mariana Y., Freude, Kristine K., Mouhammad, Zaynab A., van Wijngaarden, Peter, Martin, Keith K., Kolko, Miriam
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8007906/
https://ncbi.nlm.nih.gov/pubmed/33796062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.624983
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados